Markus Krebs
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
Papers in
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 5
- Cancer Genomics and Diagnostics 4
- Equine 1
- Co-authors
- H. RiedmillerCharis KalogirouBurkhard KneitzAndreas K. BuckConstantin LapaMartin SpahnHubert KüblerAntonio Giovanni Solimando
- Journals
- Journal of Clinical Medicine (3 papers)International Journal of Molecular Sciences (3 papers)Cancers (2 papers)Clinical and Experimental Medicine (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)
- Partner nations
- GermanyItalySwitzerland
In The Last Decade
Markus Krebs
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 342
- Pulmonary and Respiratory Medicine 547
- Radiology, Nuclear Medicine and Imaging 346
- Oncology 175
- Molecular Biology 335
Countries citing papers authored by Markus Krebs
This map shows the geographic impact of Markus Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Krebs more than expected).
Fields of papers citing papers by Markus Krebs
This network shows the impact of papers produced by Markus Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Krebs. The network helps show where Markus Krebs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Krebs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 50 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 30 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 69 | |
| 12 | 2019 | 7 | |
| 13 | 2017 | 13 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 6 | |
| 16 | 2015 | 30 | |
| 17 | 2015 | 115 | |
| 18 | 2014 | 106 | |
| 19 | 2014 | 29 | |
| 20 | 2005 | 4 |
About Markus Krebs
Markus Krebs is a scholar working on Cancer Research, Equine, Pulmonary and Respiratory Medicine, Urology and Computer Science Applications, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (7 papers), MicroRNA in disease regulation (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer-related molecular mechanisms research (5 papers), Renal and related cancers (5 papers), Cancer Genomics and Diagnostics (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (342 citations), Pulmonary and Respiratory Medicine (547 citations), Radiology, Nuclear Medicine and Imaging (346 citations), Oncology (175 citations) and Molecular Biology (335 citations). Markus Krebs has collaborated with scholars based in Germany, Italy and Switzerland. Frequent co-authors include H. Riedmiller, Charis Kalogirou, Burkhard Kneitz, Andreas K. Buck, Constantin Lapa, Martin Spahn, Hubert Kübler, Antonio Giovanni Solimando, Susanne Kneitz and Ken Herrmann. Their work appears in journals such as Journal of Clinical Medicine, International Journal of Molecular Sciences, Cancers, Clinical and Experimental Medicine and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.